The Health Professions and Programs Subcommittee received a briefing from Bobby Smith, director of the Office of Medical Marijuana Use, on program size, compliance activity, seed‑to‑sale reporting changes, licensing litigation, and rulemaking timelines; members questioned enforcement of products attractive to children and data changes tied to seed‑to‑sale implementation.